![]() "Genetics is based on innovation in the bio industry. Theragen Bio, designated as a clinical trial specimen analysis institution by the Ministry of Food and Drug Safety News Theragen Bio to participate in the 'Korean Chip Genome Information Production Project' led by the Korea Centers for Disease Control and Prevention Agency. Theragen Bio and Lotte HealthCare sign investment and strategic partnership agreement for joint healthcare research and new business development. Theragen Bio Releases The Results of Discovery of The MAST4 Protein, Controlling Bone Cartilage Differentiation Process in Nature Communications, Sister Journal of Nature PR Theragen Bio selected as the developer of AI software solutions for pediatric rare diseases by the Ministry of Science and ICT's evaluation agency. Demonstrates excellence in personal information protection PR There’s a free version, but the purchase price for this incredible plugin is only 25, well worth it Windows only. Theragen Bio renews international standard information security certification ISO 27001 and ISO 27701 for 3 consecutive years. It is incredibly useful for producing naturally eroded landscapes. Theragen Bio and Herbalife Korea launch jointly developed genetic analysis service Gene Start+ PR Theragen Bio donates cosmetics worth KRW 125 million to underprivileged groups for year-end charity PR Theragen Bio, registered 8 patents related to genomics analysis and published 21 papers. Theragen Bio acquires patent for predicting primary sites of cancer of unknown primary using genomic data. Theragen Bio and KAD sign MOU for building a domestic sewer-based monitoring System PR ![]() Theragen Bio and Agilent Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea PR ![]() Theragen Bio has obtained a patent for an NGS-based COVID-19 diagnostic and variant determination system for the advancement of infectious disease diagnosis. Theragen Bio registers a patent for the AI platform DEEPOMICS® NEO for neoantigen vaccine design. ![]()
0 Comments
Leave a Reply. |